300979984	300979984	CD	B-NP	O
|	|	NN	I-NP	O
EH	EH	NN	I-NP	O
|	|	NN	I-NP	O
36732251	36732251	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6307864	6307864	CD	B-NP	O
|	|	CC	I-NP	O
11/10/2005	11/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NNP	I-NP	I-protein
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2005	11/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2005	7/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LEGLEITER	LEGLEITER	NNP	B-NP	O
,	,	,	O	O
JASON	JASON	NNP	B-NP	O
280-33-70-9	280-33-70-9	CD	I-NP	O
Virginia	Virginia	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/27/05	2/27/05	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WOHLSCHLEGEL	WOHLSCHLEGEL	NNP	B-NP	O
,	,	,	O	O
MODESTO	MODESTO	NNP	B-NP	O
VINCE	VINCE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ROCALTROL	ROCALTROL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCITRIOL	CALCITRIOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PHOSLO	PHOSLO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1	1	CD	I-NP	O
TABLET	TABLET	NN	I-NP	O
=	=	SYM	B-VP	O
667	667	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-RRB-	-RRB-	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/13	7/13	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

IMDUR	IMDUR	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5/05	7/5/05	CD	B-NP	O
by	by	IN	B-PP	O
LINDSAY	LINDSAY	NNP	B-NP	O
,	,	,	O	O
ERIN	ERIN	NNP	B-NP	B-protein
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
IMDUR	IMDUR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
676287821	676287821	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NITROGLYCERIN	NITROGLYCERIN	NNP	B-NP	O
I.V.	I.V.	NNP	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
syncope	syncope	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	NNS	B-NP	O
as	as	IN	B-SBAR	O
outpt	outpt	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/5/05	7/5/05	CD	B-NP	O
by	by	IN	B-PP	O
LIMOLI	LIMOLI	NNP	B-NP	O
,	,	,	O	O
SAMMIE	SAMMIE	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEPHRO-VIT	NEPHRO-VIT	NN	B-NP	O
RX	RX	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
833291490	833291490	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/5/05	7/5/05	CD	B-NP	O
by	by	IN	B-PP	O
MCGHANEY	MCGHANEY	NNP	B-NP	O
,	,	,	O	O
IVORY	IVORY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/24	10/24	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
AH	AH	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
Adv.	Adv.	NN	I-NP	B-protein
as	as	IN	B-PP	O
tol	tol	NN	B-NP	O
.	.	.	O	O

/	/	SYM	O	B-protein
NAS	NAS	NN	B-NP	I-protein
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2500	2500	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	B-protein
diet	diet	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dialysis	Dialysis	NNP	B-NP	O
Saturday	Saturday	NNP	I-NP	O
12	12	CD	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
scheduled	schedule	VBD	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Precella	Precella	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
27	27	CD	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	NN	I-NP	O
at	at	IN	B-PP	O
SMH	SMH	NNP	B-NP	O
Wood	Wood	NNP	I-NP	O
scheduled	schedule	VBD	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
NITROGLYCERIN	NITROGLYCERIN	NNP	B-NP	O
I.V.	I.V.	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
CABG	CABG	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
POLYPECTOMY	POLYPECTOMY	NNP	I-NP	O
'92	'92	POS	B-NP	O
H/O	H/O	NNP	I-NP	O
NEPHROLITHIASIS	NEPHROLITHIASIS	NNP	I-NP	O
h/o	h/o	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
gastritis/duodenitis	gastritis/duodenitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
gastritis	gastritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
esophageal	esophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
cholesterol	cholesterol	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cabg	cabg	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
76	76	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	O
,	,	,	O	O
previously	previously	RB	B-NP	O
stable	stable	JJ	I-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
+	+	SYM	B-NP	O
MIBI	MIBI	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
,	,	,	O	O
gib	gib	NN	B-NP	B-protein
,	,	,	O	O
Fe-def	Fe-def	NN	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-VP	O
angina	angina	NN	B-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
MIBI	MIBI	NNP	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
bare	bare	JJ	B-NP	O
metal	metal	NN	I-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
5/22	5/22	CD	B-NP	O
Echo	Echo	NNP	I-NP	O
EF	EF	NNP	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
dil	dil	NN	B-NP	O
LV	LV	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
conc	conc	NN	I-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NNP	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
paradoxical	paradoxical	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
1/8	1/8	CD	I-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
med	me	VBN	B-VP	O
sized	sized	JJ	B-NP	O
defect	defect	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
intensity	intensity	NN	I-NP	O
in	in	IN	B-PP	O
med	med	JJ	B-NP	O
and	and	CC	I-NP	O
basal	basal	JJ	I-NP	O
ant	ant	JJ	I-NP	O
and	and	CC	I-NP	O
anterolat	anterolat	JJ	I-NP	O
wall	wall	NN	I-NP	O
with	with	IN	B-PP	O
mod	mod	NN	B-NP	O
reversibility	reversibility	NN	I-NP	O
11/9	11/9	CD	I-NP	O
CATH	CATH	NN	I-NP	O
:	:	:	O	O
Only	Only	RB	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
patent	patent	NN	I-NP	O
of	of	IN	B-PP	O
grafts	graft	NNS	B-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
bare	bare	JJ	B-NP	O
metal	metal	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
1AVG	1AVG	NN	B-NP	O
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
Admission	Admission	NN	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
96.6	96.6	CD	B-NP	O
,	,	,	I-NP	O
62	62	CD	I-NP	O
,	,	,	I-NP	O
166/70	166/70	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
pale	pale	JJ	B-NP	O
Heart	Heart	NNP	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-VP	O
ear	ear	VB	I-VP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	O
Lungs	Lungs	NNP	I-NP	O
:	:	:	O	O
clear	clear	JJ	B-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
NTND	NTND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
Bouchard	Bouchard	NNP	B-NP	O
's	's	POS	B-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DPs	DP	NNS	I-NP	O
,	,	,	O	O
palp	palp	NN	B-NP	O
thrill	thrill	NN	I-NP	O
in	in	IN	B-PP	O
LUE	LUE	NN	B-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
Groin	Groin	NN	I-NP	O
:	:	:	O	O
w/o	w/o	NN	B-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
by	by	IN	B-PP	O
System	System	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
I	I	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
24	24	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
Proximal	Proximal	NNP	B-NP	O
LCx	LCx	NNP	I-NP	O
,	,	,	O	O
Rt	Rt	NNP	B-NP	O
LV-BR	LV-BR	NNP	I-NP	O
mid	mid	VBD	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LIMA	LIMA	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
LAD	LAD	NN	I-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

Stented	Stente	VBN	B-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
bare	bare	JJ	B-NP	O
metal	metal	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

TPW	TPW	NN	B-NP	B-protein
placed	place	VBD	B-VP	O
,	,	,	O	O
then	then	RB	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
.	.	.	O	O

AM	AM	NN	B-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	I-NP	O
ccb	ccb	NN	I-NP	O
and	and	CC	I-NP	O
nitrate	nitrate	NN	I-NP	O
.	.	.	O	O

Held	Held	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
since	since	IN	B-PP	O
started	start	VBN	B-NP	O
dialysis	dialysis	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
attend	attend	VB	I-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
Kept	Kept	NNP	B-NP	O
on	on	IN	B-PP	O
ISS	ISS	NNP	B-NP	O
,	,	,	O	O
changed	change	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
glipizide	glipizide	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Anemic	Anemic	NNP	B-NP	O
,	,	,	O	O
Fe	Fe	NNP	B-NP	O
def	def	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
niferex	niferex	NN	B-NP	B-protein
per	per	IN	B-PP	I-protein
home	home	NN	B-NP	I-protein
regimen	regimen	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
replaced	replace	VBN	B-VP	O
prn	prn	NN	B-NP	O
.	.	.	O	O

Maintained	Maintain	VBN	B-VP	O
on	on	IN	B-PP	O
phoslo	phoslo	NN	B-NP	O
,	,	,	O	O
nephrovite	nephrovite	NN	B-NP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
,	,	,	I-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
diet	diet	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Ppx	Ppx	NN	B-NP	B-protein
:	:	:	O	O
sc	sc	NN	B-NP	O
hep	hep	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Mays	Mays	NNP	I-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	VBP	B-VP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
prescribed	prescribe	VBN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
attend	attend	VB	B-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
cardiology	cardiology	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
find	find	VBP	B-VP	O
concerning	concern	VBG	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HARRALSON	HARRALSON	NNP	B-NP	O
,	,	,	O	O
OTHA	OTHA	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WZ70	WZ70	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/27/05	2/27/05	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

